Pages that link to "Q58204839"
Jump to navigation
Jump to search
The following pages link to Etanercept (ETN) with methotrexate (MTX) is better than ETN monotherapy in patients with active rheumatoid arthritis despite MTX therapy: a randomized trial (Q58204839):
Displaying 25 items.
- Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis (Q24185797) (← links)
- Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis (Q26852235) (← links)
- TNF inhibitor therapy for rheumatoid arthritis (Q28972424) (← links)
- Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis. (Q30235341) (← links)
- Retrospective cohort study of anti-tumor necrosis factor agent use in a veteran population (Q33667897) (← links)
- Comparative efficacy of biological agents in methotrexate-refractory rheumatoid arthritis patients: a Bayesian mixed treatment comparison (Q33690668) (← links)
- The CEDAR Study: A Longitudinal Study of the Clinical Effects of Conventional DMARDs and Biologic DMARDs in Australian Rheumatology Practice (Q33775593) (← links)
- Systematic review and network meta-analysis of combination and monotherapy treatments in disease-modifying antirheumatic drug-experienced patients with rheumatoid arthritis: analysis of American College of Rheumatology criteria scores 20, 50, and 70 (Q34523450) (← links)
- Comparison of tocilizumab and tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective analysis of 1603 patients managed in routine clinical practice (Q35193108) (← links)
- Studies of the efficacy and safety of methotrexate at dosages over 8 mg/week using the IORRA cohort database (Q35610255) (← links)
- Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapy (Q35617683) (← links)
- Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA). (Q36195284) (← links)
- Systematic review and network meta-analysis of the efficacy and safety of tumour necrosis factor inhibitor-methotrexate combination therapy versus triple therapy in rheumatoid arthritis (Q37587412) (← links)
- The Japanese experience with biologic therapies for rheumatoid arthritis. (Q37793831) (← links)
- Revolutionary Change in Rheumatoid Arthritis Managementwith Biological Therapy (Q37943237) (← links)
- Etanercept: a review of its use in autoimmune inflammatory diseases (Q38230740) (← links)
- Optimal dose of etanercept in the treatment of rheumatoid arthritis (Q38993316) (← links)
- A multicenter, randomized, double-blind clinical trial of combination therapy with Anbainuo, a novel recombinant human TNFRII:Fc fusion protein, plus methotrexate versus methotrexate alone or Anbainuo alone in Chinese patients with moderate to sever (Q45361413) (← links)
- Targeting lymphatic function as a novel therapeutic intervention for rheumatoid arthritis. (Q48542106) (← links)
- Monotherapy with tocilizumab or TNF-alpha inhibitors in patients with rheumatoid arthritis: efficacy, treatment satisfaction, and persistence in routine clinical practice (Q50964701) (← links)
- Additional effect of etanercept or infliximab on the liver function tests of patients with rheumatoid arthritis: a cohort study (Q57817317) (← links)
- Review of Biosimilar Trials and Data on Etanercept in Rheumatoid Arthritis (Q58563236) (← links)
- Efficacy of Monotherapy with Biologics and JAK Inhibitors for the Treatment of Rheumatoid Arthritis: A Systematic Review (Q58732393) (← links)
- Which subgroup of rheumatoid arthritis patients benefits from switching to tocilizumab versus etanercept after previous infliximab failure? A retrospective study (Q84459290) (← links)
- Clinical outcome in patients with rheumatoid arthritis switched to tocilizumab after etanercept or infliximab failure (Q85522624) (← links)